USANA Health Sciences Inc (NYSE: USNA) has reported E.P.S. of $-0.36 for its third fiscal quarter (ending September 30) versus $0.56 for the same period a year ago — a decline of -164%. Relative to the consensus estimate of $-0.15, this was a shortfall of $-0.21. For the latest four quarters through September 30, E.P.S. were $0.90 compared to $2.84 a year ago — a decline of -68%.
Recent Price Action
USANA Health Sciences Inc (NYSE: USNA) stock closed at $20.91 on 10/22/25 after a slight decline of -0.6%. Moreover, this decline was accompanied by unusually high trading volume at 177% of normal. The stock has declined -1.4% during the last week and has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
USANA Health Sciences has a current Value Trend Rating of C (Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. USANA Health Sciences has a good Appreciation Score of 83 but a poor Power Rating of 26, resulting in the Neutral Value Trend Rating.
Rating Review
In light of this discouraging new earnings information and negative market action we are reviewing our current Overall Rating of C. We would view the shares with caution pending completion of this review in the next several days.
Be the first to comment